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Background: Long-term heavy cannabis use has been shown to result in 
changes to the structure and function of the brain and is thought to be a 
component cause of triggering schizophrenia in vulnerable individuals. Little is 
known about what constitutes vulnerability to psychosis in the context of 
cannabis use or indeed vulnerability toward other adverse effects to the brain. 
This study aimed to investigate potential genetic vulnerability to such adverse 
effects in long-term cannabis users.  
Methods: A range of structural and functional magnetic resonance imaging data, 
electrophysiological, cognitive, neuropsychological and clinical symptomatic 
measures were investigated from two separate studies of long-term heavy 
cannabis users (combined sample n=130) and matched non-user controls.  
Modulation of effects of cannabis use on these measures by single nucleotide 
polymorphisms (SNPs) from a range of candidate genes implicated in 
schizophrenia or involved in cognition and brain cellular and functional integrity 
was examined.  
Results: Variation in several genes was found to be associated with functional 
and brain structural outcomes. In particular, gene x group interactions were 
observed involving variations in the COMT gene in association with greater 
reduction of hippocampal and amygdala volumes and in modulating reduction of 
the mismatch negativity (MMN) event-related potential. There was also evidence 
of epistasis between several of the candidate genes investigated, and evidence of 
genetic modulation of some of the cognitive and symptomatic measures.  
Discussion: The results of this investigation implicate several genes in 
modulating the long-term effects of cannabis on brain structure and function. 
The implications of these findings may guide our understanding of vulnerability 
toward the adverse effects of cannabis on the brain, including the propensity for 
cannabis to trigger psychosis.  
 
